Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Guzhi Pharmaceutical Technology is a biotechnology company specializing in AI-driven drug discovery and development. The company leverages advanced computational platforms to identify and optimize small molecule candidates for challenging therapeutic targets, particularly in the fields of oncology and immunology. By integrating artificial intelligence with structural biology and medicinal chemistry, Guzhi Pharmaceutical aims to accelerate the transition from target identification to clinical candidates. The firm focuses on "undruggable" proteins and protein-protein interactions, seeking to provide innovative solutions for unmet medical needs. Based in Guangzhou, the company is part of the emerging cluster of high-tech biopharmaceutical startups in the Greater Bay Area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Guzhi Pharmaceutical Technology.